JP2010222367A5 - - Google Patents

Download PDF

Info

Publication number
JP2010222367A5
JP2010222367A5 JP2010126874A JP2010126874A JP2010222367A5 JP 2010222367 A5 JP2010222367 A5 JP 2010222367A5 JP 2010126874 A JP2010126874 A JP 2010126874A JP 2010126874 A JP2010126874 A JP 2010126874A JP 2010222367 A5 JP2010222367 A5 JP 2010222367A5
Authority
JP
Japan
Prior art keywords
botulinum toxin
composition
composition according
modified botulinum
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010126874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010222367A (ja
Filing date
Publication date
Priority claimed from US10/183,221 external-priority patent/US6776991B2/en
Application filed filed Critical
Publication of JP2010222367A publication Critical patent/JP2010222367A/ja
Publication of JP2010222367A5 publication Critical patent/JP2010222367A5/ja
Pending legal-status Critical Current

Links

JP2010126874A 2002-06-26 2010-06-02 持続勃起症を処置するためのボツリヌス毒素 Pending JP2010222367A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/183,221 US6776991B2 (en) 2002-06-26 2002-06-26 Methods for treating priapism

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004517780A Division JP4602762B2 (ja) 2002-06-26 2003-06-24 持続勃起症を処置するためのボツリヌス毒素

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013116719A Division JP2013166792A (ja) 2002-06-26 2013-06-03 持続勃起症を処置するためのボツリヌス毒素

Publications (2)

Publication Number Publication Date
JP2010222367A JP2010222367A (ja) 2010-10-07
JP2010222367A5 true JP2010222367A5 (enExample) 2011-08-25

Family

ID=29779076

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004517780A Expired - Fee Related JP4602762B2 (ja) 2002-06-26 2003-06-24 持続勃起症を処置するためのボツリヌス毒素
JP2010126874A Pending JP2010222367A (ja) 2002-06-26 2010-06-02 持続勃起症を処置するためのボツリヌス毒素
JP2013116719A Pending JP2013166792A (ja) 2002-06-26 2013-06-03 持続勃起症を処置するためのボツリヌス毒素

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004517780A Expired - Fee Related JP4602762B2 (ja) 2002-06-26 2003-06-24 持続勃起症を処置するためのボツリヌス毒素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013116719A Pending JP2013166792A (ja) 2002-06-26 2013-06-03 持続勃起症を処置するためのボツリヌス毒素

Country Status (10)

Country Link
US (1) US6776991B2 (enExample)
EP (1) EP1515735B1 (enExample)
JP (3) JP4602762B2 (enExample)
AT (1) ATE347898T1 (enExample)
AU (1) AU2003243770B2 (enExample)
BR (1) BR0312099A (enExample)
CA (1) CA2489239C (enExample)
DE (1) DE60310400T2 (enExample)
ES (1) ES2278196T3 (enExample)
WO (1) WO2004002502A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360712A1 (en) * 2001-12-21 2003-07-30 The Trustees Of Columbia University In The City Of New York C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis
US20040067235A1 (en) * 2002-07-29 2004-04-08 Rajiv Doshi Methods for the use of neurotoxin in the treatment of urologic disorders
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
US7608275B2 (en) 2005-07-22 2009-10-27 The Foundry, Llc Systems and methods for delivery of a therapeutic agent
US12433837B2 (en) 2005-07-22 2025-10-07 The Foundry, Llc Systems and methods for delivery of a therapeutic agent
US10052465B2 (en) 2005-07-22 2018-08-21 The Foundry, Llc Methods and systems for toxin delivery to the nasal cavity
US7655243B2 (en) 2005-07-22 2010-02-02 The Foundry, Llc Methods and systems for toxin delivery to the nasal cavity
US20070240454A1 (en) 2006-01-30 2007-10-18 Brown David P Method and apparatus for continuous or batch optical fiber preform and optical fiber production
US7811586B2 (en) * 2006-05-02 2010-10-12 Allergan, Inc. Methods for alleviating testicular pain
US20070283969A1 (en) * 2006-06-12 2007-12-13 Medtronic Vascular, Inc. Method of Diagnosing and Treating Erectile Dysfunction
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
CN112089394A (zh) 2009-10-27 2020-12-18 努瓦拉公司 具有可冷却的能量发射组件的递送装置
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
EP2498705B1 (en) 2009-11-11 2014-10-15 Holaira, Inc. Device for treating tissue and controlling stenosis
JP6470678B2 (ja) 2012-04-13 2019-02-13 ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド ニューロンの開口分泌を阻害する化合物（ｉｉ）
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
AU4646393A (en) * 1992-06-23 1994-01-24 Interactive Biologics Associates Pharmaceutical composition containing botulinum b complex
US5439938A (en) * 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
DE69434443T2 (de) 1993-12-28 2006-05-24 Allergan, Inc., Irvine Verwendung der neutrotoxischen Komponente des Botulinum Toxins zur Muskelschmerzbehandlung
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
AU695623B2 (en) * 1994-05-31 1998-08-20 Allergan, Inc. Modification of clostridial toxins for use as transport proteins
US5562899A (en) * 1995-02-28 1996-10-08 Gerber; Allen Medical prevention of lacerations to the vagina and perineum
ATE314085T1 (de) * 1997-07-15 2006-01-15 Univ Colorado Verwendung von botulinumtoxin zur behandlung von harninkontinenz
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6376460B2 (en) * 1998-08-07 2002-04-23 Flinders Technologies Pty. Ltd. Method of modulating cellular activity
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
SG99857A1 (en) * 1999-11-18 2003-11-27 Univ Singapore A method of treatment and prophylaxis
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
JP4602752B2 (ja) * 2004-01-14 2010-12-22 帝人株式会社 撚糸、撚糸の製造方法および撚糸の製造装置

Similar Documents

Publication Publication Date Title
JP2010222367A5 (enExample)
JP2014505733A5 (enExample)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
JP2013520405A5 (enExample)
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
EA201170018A1 (ru) Разагилин для изменения течения болезни паркинсона
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
BRPI0908124A2 (pt) Composto, ativador de glucoquinase, composição farmacêutica, uso de um composto ou sal farmacologicamente aceitavél do mesmo, e, métodos de ativação da glucoquinase, e para tratar e/ou prevenir uma doença
MX2013003635A (es) Compuestos de n-heteroarilo.
CL2011002847A1 (es) Uso de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida o una sal farmaceuticamente aceptable del mismo y un inhibidor de acetilcolinesterasa para preparar un medicamento util para mejorar la cognicion.
UA107550C2 (uk) Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів
JP2012517449A5 (enExample)
MA37455A1 (fr) Utilisation d'un dérivé de pyrazole dans le traitement d'exacerbations aigues d'une maladie pulmonaire obstructive chronique
JP2014520892A5 (enExample)
EA201591653A1 (ru) Композиции для лечения глазных расстройств с применением дипиридамола
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
BRPI0918593A2 (pt) composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente
AR074246A1 (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno
WO2009137436A3 (en) Peptide conjugates
AR068608A1 (es) Neramexano para el tratamiento de nistagmo